GregoryPaulBissonMD
Infectious Disease • Philadelphia, PAAssistant Professor, Medicine, Perelman School of Medicine
Are you Dr. Bisson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6932Fax+1 215-662-7899
Summary
- Dr. Gregory Bisson, MD is an infectious disease specialist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 2000 - 2003- University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 2000
University of Minnesota Medical SchoolClass of 1997
Certifications & Licensure
PA State Medical License 1998 - 2024
Clinical Trials
- Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 5 citationsOptimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.Krina Mehta, Shruthi Ravimohan, Jotam G. Pasipanodya, Shashikant Srivastava, Chawangwa Modongo
The Journal of Antimicrobial Chemotherapy. 2019-10-01 - 31 citationsMatrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating ...Shruthi Ravimohan, Neo Tamuhla, Shiang-Ju Kung, Kebatshabile Nfanyana, Andrew P. Steenhoff
Ebiomedicine. 2016-01-01 - 18 citationsEarly antiretroviral therapy is protective against epilepsy in children with human immunodeficiency virus infection in botswana.David Bearden, Andrew P. Steenhoff, Dennis J. Dlugos, Dennis L. Kolson, Parth S. Mehta
Journal of Acquired Immune Deficiency Syndromes. 2015-06-01
Press Mentions
Treating HIV and Tuberculosis Simultaneously Could Greatly Boost Patient SurvivalAugust 26th, 2020- Penn Medicine-Led Research Suggests Greater Access to Specific HIV and Tuberculosis Medications Is Needed WorldwideAugust 6th, 2020
Grant Support
- Immunology And Outcomes After Haart In Hiv/Tb CoinfectionNational Institute Of Allergy And Infectious Diseases2009–2012
- Effect Of GBV-C On HIVNational Institute Of Allergy And Infectious Diseases2004–2008
